We are live on ! Find out more
CRVO icon

CervoMed
CRVO

8 hedge funds and large institutions have $513K invested in CervoMed in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5,600% more capital invested

Capital invested by funds: $9K → $513K (+$504K)

300% more funds holding

Funds holding: 2 → 8 (+6)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
8
Holders Change
+6
Holders Change %
+300%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$258K
2
Goldman Sachs
Goldman Sachs
New York
+$60.1K
3
VKH
Virtu KCG Holdings
New York
+$60.1K
4
Morgan Stanley
Morgan Stanley
New York
+$47.2K
5
WTC
WhitTier Trust Company
Nevada
+$38.6K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$270K +$258K +60 New
VKH
2
Virtu KCG Holdings
New York
$64K +$60.1K +14 New
Goldman Sachs
3
Goldman Sachs
New York
$61K +$60.1K +14 New
Morgan Stanley
4
Morgan Stanley
New York
$50K +$47.2K +11 New
WTC
5
WhitTier Trust Company
Nevada
$40K +$38.6K +9 New
AG
6
Advisor Group
Arizona
$17K +$8.59K +2 +100%
PNC Financial Services Group
7
PNC Financial Services Group
Pennsylvania
$6K – – –
UBS Group
8
UBS Group
Switzerland
$5K +$4.29K +1 New
TRCT
9
Tower Research Capital (TRC)
New York
– -$1K – –

CRVO Hedge Fund Activity: Q1 2017 in Review

8 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2017, worth a combined $513K — up 5,600% from $9K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CRVO positions and 0 closed out — a net gain of 6 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $258K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1K.

  • 8 institutional investors held CervoMed (CRVO) as of Q1 2017, up from 2 in Q4 2016.
  • Funds reported $513K of CervoMed stock for Q1 2017, up 5,600% quarter-over-quarter.
  • 6 funds opened new CervoMed positions in Q1 2017 and 0 closed out, a net change of +6 holders.
  • The largest CervoMed buyer in Q1 2017 was Vanguard Group, an estimated $258K added.
  • The largest CervoMed seller in Q1 2017 was Tower Research Capital (TRC), an estimated $1K sold.

Based on aggregated 13F filings for Q1 2017.